Zhejiang Hengtong Stock Hits Day Low of CNY 5.95 Amid Price Pressure

Zhejiang Hengtong Holding Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 3.71% on February 24, 2026. The stock reached an intraday low of CNY 5.95, reflecting a challenging trading session. In terms of performance metrics, Zhejiang Hengtong has shown a year-to-date increase of 12.01%, significantly outperforming the China Shanghai Composite, which has risen by only 2.85% during the same period. Over the past year, the stock has delivered an impressive return of 118.68%, compared to the composite's 22.49%. However, the company's long-term growth appears to be under pressure, with net sales growing at an annual rate of 22.59% and operating profit at 11.94% over the last five years. The company's financial health is characterized by a debt-equity ratio of 0.09 and a return on equity of 5.60%. Despite these metrics, the stock's price-to-earnings ratio stands at 63.00, indicating a premium valuation in the current market environment.